SPL 7.14% 10.5¢ starpharma holdings limited

Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-13

  1. 15,448 Posts.
    lightbulb Created with Sketch. 5532
    Here We Go finally results that can be partnered with big Pharma for big bucks


    Not what the new CEO Cheryl said in the Webinar @thrasher .... but hey don't take my word for it - here's the link to the Webinar from the Starpharma website ....she clearly states big pharma aren't interested in our DEP drugs at this stage so hardly a 'game changer' today on the back of these results ?


    https://starpharma.com/news/story/investor-webinar-starpharma-business-update-22-may-2024
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.007(7.14%)
Mkt cap ! $43.29M
Open High Low Value Volume
9.5¢ 10.5¢ 9.5¢ $8.154K 83.09K

Buyers (Bids)

No. Vol. Price($)
1 5102 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 124847 3
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.